RxSight, Inc.·4

Jun 18, 4:06 PM ET

Tammenoms Bakker Juliet 4

4 · RxSight, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

RxSight Director Juliet Tammenoms Bakker Receives 37,037-Share Award

What Happened

  • Juliet Tammenoms Bakker, a member of the RxSight (RXST) board of directors, received an award of 37,037 restricted stock units (RSUs) on June 17, 2026 (transaction code A = award/grant). No purchase price or cash changed hands; the filing reports an acquisition of contingent RSUs rather than a market buy. The filing does not disclose a dollar value for the award.

Key Details

  • Transaction date: 2026-06-17 (Form 4 filed 2026-06-18 — timely filing).
  • Amount: 37,037 RSUs; price: N/A (award/grant).
  • Shares owned after transaction: not specified in the report.
  • Vesting: 100% of the RSUs vest on the earlier of (i) one year after the grant (June 17, 2027) or (ii) the date of the next annual meeting, contingent on continued service as an Outside Director per the 2021 Equity Incentive Plan.
  • Holding structure: the RSUs are held by a trust for which the reporting person is Investment Trustee; she disclaims beneficial ownership except to the extent of pecuniary interest (see footnote).
  • Exhibit included: Exhibit 24 — Power of Attorney.

Context

  • Each RSU represents a contingent right to one share of RxSight common stock upon vesting and any required settlement; this is a typical form of non-cash director compensation and not an open-market purchase or sale. Such awards become meaningful only if and when they vest and convert to shares (and may be subject to tax withholding). This filing signals a grant of equity compensation, not an immediate change in market holdings.

Insider Transaction Report

Form 4
Period: 2026-06-17
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-06-17+37,03785,183 total
Holdings
  • Common Stock

    [F3]
    (indirect: See footnote)
    1,548
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
  • [F2]Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
  • [F3]These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
Signature
/s/ Jim Schindler, as Attorney-in-Fact|2026-06-18

Documents

2 files